MarketsA-shares

Funds Research Nine Companies; Haichuang Pharma Draws 11 Funds

Published: Updated: By 24TopNews Editorial Desk

On September 14, 2026, institutions researched 21 companies, with funds participating in research on nine of them. Haichuang Pharma drew 11 funds, the most, followed by Sichuan Shuangma with four and Shengda Resources with two. Among the fund-researched stocks, only Yibo Technology rose over the past five days, gaining 8.77%, while eight declined, led by Sichuan Shuangma, Shengda Resources and Haichuang Pharma. Yibo Technology recorded the largest net inflow at RMB 191 million.

On September 14, 2026, a total of 21 companies were researched by institutions, with funds taking part in research on nine of them.

Haichuang Pharma drew the most attention, with 11 funds participating in its research. Sichuan Shuangma was researched by four funds, and Shengda Resources by two.

By board, six of the fund-researched companies are listed on the Shenzhen Main Board, two on ChiNext and one on the STAR Market.

By total A-share market capitalization, one fund-researched company exceeded RMB 50 billion, including SF Holding, which is valued at more than RMB 100 billion. Four companies had a total market capitalization below RMB 10 billion, namely Haichuang Pharma, Arrow Home and Sujiaoke, among others.

In terms of market performance, among the fund-researched stocks, one rose over the past five days: Yibo Technology, with a gain of 8.77%. Eight declined, with Sichuan Shuangma, Shengda Resources and Haichuang Pharma posting the largest drops, of 5.63%, 5.26% and 4.16%, respectively.

Among the fund-researched stocks, five recorded net capital inflows over the past five days. Yibo Technology saw the largest net inflow of main capital, at RMB 191 million, followed by Hegang Resources with RMB 57.1316 million and Sichuan Shuangma with RMB 18.6861 million.

Specifically, Haichuang Pharma was researched by 11 funds, with a latest closing price of RMB 29.72 and a five-day change of -4.16%; it operates in the pharmaceutical and biotechnology industry. Sichuan Shuangma was researched by four funds, with a latest closing price of RMB 20.44 and a five-day change of -5.63%; it operates in the non-bank financial sector. Sujiaoke was researched by two funds, with a latest closing price of RMB 5.09 and a five-day change of -1.55%; it operates in the building decoration industry. Shengda Resources was researched by two funds, with a latest closing price of RMB 33.50 and a five-day change of -5.26%; it operates in the non-ferrous metals industry.

SF Holding was researched by one fund, with a latest closing price of RMB 30.98 and a five-day change of -2.43%; it operates in the transportation industry. Huikang Technology was researched by one fund, with a latest closing price of RMB 48.83 and a five-day change of -4.12%; it operates in the machinery and equipment industry. Arrow Home was researched by one fund, with a latest closing price of RMB 6.35 and a five-day change of -2.46%; it operates in the light industry manufacturing sector. Yibo Technology was researched by one fund, with a latest closing price of RMB 62.86 and a five-day change of 8.77%; it operates in the electronics industry. Hegang Resources was researched by one fund, with a latest closing price of RMB 16.35 and a five-day change of -1.03%; it operates in the steel industry.